Skip to main content
Premium Trial:

Request an Annual Quote

Diploid's Diagnosed

Diploid has launched Diagnosed, a new clinical interpretation service for rare disease diagnostics based on whole-genome sequencing data. The service, priced at $699, targets variants associated with intellectual disabilities, dysmorphisms, metabolic conditions, blindness, and deafness. If it's tools cannot identify a SNP or structural variant in the sample, Diploid will not charge for its service. 

The company has also added a new tool for copy number variation detection to its portfolio that it claims is about 80x more sensitive than traditional array CGH tests and more cost-effective.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.